243.34
price up icon0.44%   1.295
 
loading

Finanzdaten der Johnson Johnson-Aktie (JNJ)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-28 2025-09-28 2025-06-29 2025-03-30 2024-12-29
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.38%
24,564.00
23,993.00 23,743.00 21,893.00 22,520.00
Cost Of Revenue
9.11%
7,968.00
7,303.00 7,628.00 7,357.00 7,128.00
Gross Profit
0.56%
16,596.00
16,690.00 16,115.00 14,536.00 15,392.00
Operating Expenses
26.45%
11,630.00
9,197.00 9,624.00 905.00 11,505.00
Benefits Costs and Expenses
18.78%
19,598.00
16,500.00 17,252.00 8,262.00 18,633.00
Costs And Expenses
18.78%
19,598.00
16,500.00 17,252.00 8,262.00 18,633.00
Operating Income/Loss
33.72%
4,966.00
7,493.00 6,491.00 13,631.00 3,887.00
Income/Loss From Continuing Operations Before Tax
33.72%
4,966.00
7,493.00 6,491.00 13,631.00 3,887.00
Income Tax Expense/Benefit, Deferred
265.78%
-3,677.00
2,218.00 825.00 2,172.00 -16.00
Income Tax Expense/Benefit
106.41%
-150.00
2,341.00 954.00 2,632.00 456.00
Income/Loss From Continuing Operations After Tax
0.70%
5,116.00
5,152.00 5,537.00 10,999.00 3,431.00
Net Income/Loss
0.70%
5,116.00
5,152.00 5,537.00 10,999.00 3,431.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
100.00%
0.10
2,408.30 2,406.30 2,407.20 -0.10
Diluted Average Shares
99.81%
4.60
2,428.60 2,419.10 2,423.80 -0.10
Basic Earnings Per Share
0.93%
2.12
2.14 2.30 4.57 1.42
Diluted Earnings Per Share
1.42%
2.09
2.12 2.29 4.54 1.41
Common Stock Dividends
0.00%
1.30
1.30 1.30 1.24 1.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$224.39
price down icon 0.58%
drug_manufacturers_general AZN
$189.49
price down icon 1.58%
drug_manufacturers_general NVS
$153.99
price down icon 0.21%
drug_manufacturers_general LLY
$986.57
price up icon 1.07%
drug_manufacturers_general MRK
$116.11
price up icon 0.23%
Kapitalisierung:     |  Volumen (24h):